Evaluation of core-needle biopsy in Breast Imaging Reporting and Data System 3 breast mass
Background/aim A crucial approach for finding breast cancer sooner is the triple examination of breast diseases. Our goal was to determine if ultrasound-guided core biopsies were required to investigate clinically ambiguous breast tumors that lacked imaging features suspicious for malignancy in Bre...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2023-01-01
|
| Series: | Journal of the Arab Society for Medical Research |
| Subjects: | |
| Online Access: | http://www.new.asmr.eg.net/article.asp?issn=1687-4293;year=2023;volume=18;issue=1;spage=88;epage=92;aulast=Diab |
| _version_ | 1797774089674293248 |
|---|---|
| author | Khaled Diab Mohamed F Zaidan Sameh Samir Obaida A Derballa Mahmoud I Aboelnor Hany F Habashy |
| author_facet | Khaled Diab Mohamed F Zaidan Sameh Samir Obaida A Derballa Mahmoud I Aboelnor Hany F Habashy |
| author_sort | Khaled Diab |
| collection | DOAJ |
| description | Background/aim A crucial approach for finding breast cancer sooner is the triple examination of breast diseases. Our goal was to determine if ultrasound-guided core biopsies were required to investigate clinically ambiguous breast tumors that lacked imaging features suspicious for malignancy in Breast Imaging Reporting and Data System 3.
Patients and methods A prospective study was performed on 50 patients fulfilling our eligibility criteria who presented with symptomatic indeterminate breast masses chosen according to our selection criteria and underwent an ultrasonography-guided core biopsy in the period from January 2021 to March 2022.
Results A total of 50 clinically ambiguous breast masses were investigated, of which 47 (94%) were benign lesions, including 34 (68%) lesions were fibroadenomas, six (12%) lesions were fibrocystic disorder without ductal hyperplasia, one (2%) lesion was fibrocystic disease with ductal hyperplasia with no atypia, and six (12%) lesions showed periductal mastitis. Two (4%) lesions were proliferative breast lesions with focal atypia. One (2%) lesion was infiltrating duct carcinoma grade 2.
Conclusion Ultrasound-guided core biopsy is necessary for investigating clinically indeterminate breast mass in symptomatic patients with Breast Imaging Reporting and Data System 3 finding on imaging, for early detection of malignancy and atypical hyperplastic changes. |
| first_indexed | 2024-03-12T22:15:58Z |
| format | Article |
| id | doaj.art-78e72dd9bada4e93ac4f9a1ae1a231a9 |
| institution | Directory Open Access Journal |
| issn | 1687-4293 2090-3286 |
| language | English |
| last_indexed | 2024-03-12T22:15:58Z |
| publishDate | 2023-01-01 |
| publisher | Wolters Kluwer Medknow Publications |
| record_format | Article |
| series | Journal of the Arab Society for Medical Research |
| spelling | doaj.art-78e72dd9bada4e93ac4f9a1ae1a231a92023-07-23T11:19:22ZengWolters Kluwer Medknow PublicationsJournal of the Arab Society for Medical Research1687-42932090-32862023-01-01181889210.4103/jasmr.jasmr_32_22Evaluation of core-needle biopsy in Breast Imaging Reporting and Data System 3 breast massKhaled DiabMohamed F ZaidanSameh SamirObaida A DerballaMahmoud I AboelnorHany F HabashyBackground/aim A crucial approach for finding breast cancer sooner is the triple examination of breast diseases. Our goal was to determine if ultrasound-guided core biopsies were required to investigate clinically ambiguous breast tumors that lacked imaging features suspicious for malignancy in Breast Imaging Reporting and Data System 3. Patients and methods A prospective study was performed on 50 patients fulfilling our eligibility criteria who presented with symptomatic indeterminate breast masses chosen according to our selection criteria and underwent an ultrasonography-guided core biopsy in the period from January 2021 to March 2022. Results A total of 50 clinically ambiguous breast masses were investigated, of which 47 (94%) were benign lesions, including 34 (68%) lesions were fibroadenomas, six (12%) lesions were fibrocystic disorder without ductal hyperplasia, one (2%) lesion was fibrocystic disease with ductal hyperplasia with no atypia, and six (12%) lesions showed periductal mastitis. Two (4%) lesions were proliferative breast lesions with focal atypia. One (2%) lesion was infiltrating duct carcinoma grade 2. Conclusion Ultrasound-guided core biopsy is necessary for investigating clinically indeterminate breast mass in symptomatic patients with Breast Imaging Reporting and Data System 3 finding on imaging, for early detection of malignancy and atypical hyperplastic changes.http://www.new.asmr.eg.net/article.asp?issn=1687-4293;year=2023;volume=18;issue=1;spage=88;epage=92;aulast=Diabcore biopsyindeterminate breast massesmalignancyproliferative atypia |
| spellingShingle | Khaled Diab Mohamed F Zaidan Sameh Samir Obaida A Derballa Mahmoud I Aboelnor Hany F Habashy Evaluation of core-needle biopsy in Breast Imaging Reporting and Data System 3 breast mass Journal of the Arab Society for Medical Research core biopsy indeterminate breast masses malignancy proliferative atypia |
| title | Evaluation of core-needle biopsy in Breast Imaging Reporting and Data System 3 breast mass |
| title_full | Evaluation of core-needle biopsy in Breast Imaging Reporting and Data System 3 breast mass |
| title_fullStr | Evaluation of core-needle biopsy in Breast Imaging Reporting and Data System 3 breast mass |
| title_full_unstemmed | Evaluation of core-needle biopsy in Breast Imaging Reporting and Data System 3 breast mass |
| title_short | Evaluation of core-needle biopsy in Breast Imaging Reporting and Data System 3 breast mass |
| title_sort | evaluation of core needle biopsy in breast imaging reporting and data system 3 breast mass |
| topic | core biopsy indeterminate breast masses malignancy proliferative atypia |
| url | http://www.new.asmr.eg.net/article.asp?issn=1687-4293;year=2023;volume=18;issue=1;spage=88;epage=92;aulast=Diab |
| work_keys_str_mv | AT khaleddiab evaluationofcoreneedlebiopsyinbreastimagingreportinganddatasystem3breastmass AT mohamedfzaidan evaluationofcoreneedlebiopsyinbreastimagingreportinganddatasystem3breastmass AT samehsamir evaluationofcoreneedlebiopsyinbreastimagingreportinganddatasystem3breastmass AT obaidaaderballa evaluationofcoreneedlebiopsyinbreastimagingreportinganddatasystem3breastmass AT mahmoudiaboelnor evaluationofcoreneedlebiopsyinbreastimagingreportinganddatasystem3breastmass AT hanyfhabashy evaluationofcoreneedlebiopsyinbreastimagingreportinganddatasystem3breastmass |